Statistics for serious infections contracted by long term care residents are sobering: between 1 and 3 million contract a serious infection annually, even under normal operating conditions. These infections are increasingly becoming antimicrobial resistant and lethal, causing over 380,000 deaths per year in the U.S. alone. While senior living has always been hyper-vigilant to contain outbreaks, COVID-19 has upped the ante for infection control across the continuum of care, including the need to effectively balance infection prevention and safety with operational efficiency. Topics such as isolation practices and their impact on resident quality of life, as well as the role of testing and health screening for residents and employees, will also be discussed.
Rosie Lyles, MD, MHA, MSc, FACA, Director of Clinical Affairs, Medline Industries, Inc.
Schekesia Meadough, BSN, RN, CDP, Vice President of Quality & Clinical Operations, American House Senior Living Communities
Ruth Petran, PhD., CFS, Senior Corporate Scientist, Food Safety and Public Health, Ecolab
Charles E. Trefzger, President and CEO, ALG Senior
Kevin W. O’Neil, MD, FACP, CMD, Chief Medical Officer, ALG Senior